The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis

BACKGROUND: Obesity and insulin resistance (IR) are common in polycystic ovary syndrome (PCOS), which contribute to reproductive and metabolic abnormalities. Metformin increases insulin sensitivity, but it is associated with unsatisfied benefits of weight loss. Recent studies have reported that gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ruilin, Ding, Xuesong, Wang, Yanfang, Deng, Yan, Sun, Aijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202615/
https://www.ncbi.nlm.nih.gov/pubmed/34115034
http://dx.doi.org/10.1097/MD.0000000000026295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202615/
https://www.ncbi.nlm.nih.gov/pubmed/34115034
http://dx.doi.org/10.1097/MD.0000000000026295

Ejemplares similares